CGG : Information mensuelle relative au nombre total de drotis de vote et d'actions composant le capital
CGG Société anonyme au capital de 7 099 443 eurosSiège social : Tour Maine Montparnasse33 avenue du Maine 75015 Paris969 202 […]
CGG : Montly information relating to the number of voting rights and shares issued
CGG A French société anonymewith a share capital of € 7,099,443Registered office : Tour Maine Montparnasse33 avenue du Maine 75015 […]
Gladstone Land Acquires Almond Orchard in California for $8.2 Million
MCLEAN, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) — Gladstone Land Corporation (NASDAQ: LAND) (“Gladstone Land” or the “Company”) announced that […]
First Bauxite Shareholders Approve Going Private Transaction; Notified of Court Petition
NEW ORLEANS, La., Dec. 10, 2018 (GLOBE NEWSWIRE) — First Bauxite Corporation (“First Bauxite” or the “Company”) is pleased to […]
STMicroelectronics Now Sampling Embedded PCM for Automotive Microcontrollers
Innovative embedded Phase-Change Memory (ePCM) for automotive MCUs sampling now Initial performance benchmarks presented at IEDM 2018 Will support […]
Sunniva Inc. Announces Resignation of President of Natural Health Services Ltd.
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) — Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), […]
Chaparral Energy Announces Borrowing Base Increase
OKLAHOMA CITY, Dec. 10, 2018 (GLOBE NEWSWIRE) — Chaparral Energy, Inc. (NYSE: CHAP) announced today the company’s bank group has […]
Norwegian Cruise Line Holdings Ltd. Announces Appointment of Harry Sommer as President, International
MIAMI, Dec. 10, 2018 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“Norwegian Cruise Line Holdings”, “Norwegian” or […]
The Madison Square Garden Company Announces Financial Leadership Changes
Current Chief Financial Officer, Donna Coleman, to Retire; Victoria Mink to Be Named Executive Vice President and Chief Financial Officer […]
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
Phase 1b study includes Parkinson’s disease patients with and without a genetic LRRK2 mutation SOUTH SAN FRANCISCO, Calif., Dec. 10, […]
